FFA
NVO

Frazier Financial Advisors’s Novo Nordisk NVO Stock Holding History

Frazier Financial Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.8K Sell
935
-469
-33% -$20.1K 0.02% 196
2026
Q1 		$51.6K Sell
1,404
-3,074
-69% -$146K 0.03% 180
2025
Q4 		$228K Buy
4,478
+1,550
+53% +$79.3K 0.13% 59
2025
Q3 		$162K Buy
2,928
+200
+7% +$11.7K 0.1% 74
2025
Q2 		$188K Buy
2,728
+371
+16% +$25.2K 0.13% 63
2025
Q1 		$164K Buy
2,357
+90
+4% +$7.43K 0.13% 62
2024
Q4 		$194K Sell
2,267
-103
-4% -$11.1K 0.15% 55
2024
Q3 		$282K Buy
2,370
+514
+28% +$68.5K 0.22% 41
2024
Q2 		$265K Buy
1,856
+118
+7% +$15.6K 0.21% 47
2024
Q1 		$223K Buy
1,738
+215
+14% +$25.6K 0.18% 51
2023
Q4 		$158K Buy
+1,523
New +$151K 0.14% 57

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Frazier Financial Advisors's NVO Position: Q2 2026 in Review

Frazier Financial Advisors reduced its Novo Nordisk (NVO) stake by 33% in Q2 2026, selling an estimated $20.1K and leaving 935 shares worth $44.8K. The position accounts for 0.02% of the portfolio, ranked #196.

Frazier Financial Advisors first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $282K in Q3 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Frazier Financial Advisors held 935 shares of Novo Nordisk worth $44.8K as of Q2 2026.
  • Frazier Financial Advisors sold 469 Novo Nordisk shares in Q2 2026, an estimated $20.1K.
  • Novo Nordisk made up 0.02% of Frazier Financial Advisors's portfolio in Q2 2026, its #196 holding.
  • Frazier Financial Advisors first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • Frazier Financial Advisors's Novo Nordisk position peaked at $282K in Q3 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Frazier Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.